Immunai Acquires Dropprint Genomics and Strengthens Leadership Team with Experts in Immunology to Expand Target Discovery Capabilities

- Peter Smibert, PhD, former Director of Technology Innovation at New York Genome Center, is joining Immunai as Vice President of Functional Genomics. Smibert?s lab pioneered the development of single cell multiomics and functional genomics tools, including CITE-seq, ECCITE-seq, and ASAP-seq, which are integral to the ongoing work at Immunai.
- Alexandria Cogdill, MEng, PhD, joins Immunai as Director of Business Development from UT MD Anderson Cancer Center, where she was a Strategic Industry Ventures Fellow while completing her PhD in immunology with Dr. Jim Allison. In addition to her work in BD and corporate strategy, Dr. Cogdill has published over?50 scientific articles and worked as a researcher and laboratory operations manager with Dr. Steve Rosenberg at the NIH, Dr. Jennifer Wargo at Harvard Medical School, and Dr. Carl June at the University of Pennsylvania.
- Adeeb Rahman, PhD, is joining Immunai as Senior Director of Single-Cell Immunology. Rahman, a cellular immunologist, previously served as the Director of Technology Development for the Human Immune Monitoring Center at the Icahn School of Medicine at Mt. Sinai, where he led one of the world?s largest academic service labs offering comprehensive solutions for high-dimensional single-cell characterization.
- Danny Wells, PhD, a Scientific Co-founder of Immunai, is joining as Senior Vice President of Strategic Research. Wells was previously the founding data scientist and head of reverse translational medicine at the Parker Institute for Cancer Immunotherapy. His group there contributed to pioneering discoveries in the mechanisms of response and resistance to cancer immunotherapies published in Nature, Cell, and Nature Medicine.